Xometry (NASDAQ:XMTR) CEO Randolph Altschuler Sells 31,928 Shares

Xometry, Inc. (NASDAQ:XMTR) CEO Randolph Altschuler sold 31,928 shares of the company’s stock in a transaction that occurred on Thursday, February 26th. The stock was sold at an average price of $43.44, for a total value of $1,386,952.32. Following the completion of the transaction, the chief executive officer owned 372,377 shares of the company’s stock, valued at approximately $16,176,056.88. This represents a 7.90% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Randolph Altschuler also recently made the following trade(s):

• On Monday, January 5th, Randolph Altschuler sold 14,826 shares of Xometry stock. The stock was sold at an average price of $66.53, for a total transaction of $986,373.78.

Xometry Stock Up 8.2%

Shares of NASDAQ:XMTR opened at $45.26 on Friday. The stock has a market capitalization of $2.32 billion, a price-to-earnings ratio of -37.10 and a beta of 0.86. Xometry, Inc. has a 1-year low of $18.59 and a 1-year high of $73.87. The company has a debt-to-equity ratio of 1.18, a quick ratio of 3.58 and a current ratio of 3.76. The company’s fifty day moving average is $61.06 and its two-hundred day moving average is $56.04.

Xometry (NASDAQ:XMTR) last posted its earnings results on Tuesday, February 24th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.04. The firm had revenue of $192.40 million during the quarter, compared to analyst estimates of $183.37 million. Xometry had a negative net margin of 8.99% and a negative return on equity of 5.49%. Xometry’s revenue was up 29.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.06 EPS. Equities analysts anticipate that Xometry, Inc. will post -0.66 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have issued reports on XMTR shares. JPMorgan Chase & Co. increased their price target on Xometry from $55.00 to $70.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. The Goldman Sachs Group boosted their price target on shares of Xometry from $49.00 to $56.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 5th. Citizens Jmp set a $75.00 price objective on shares of Xometry in a research report on Wednesday, November 5th. Royal Bank Of Canada dropped their target price on shares of Xometry from $64.00 to $55.00 and set a “sector perform” rating on the stock in a report on Wednesday. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Xometry in a report on Wednesday, January 21st. Five investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $62.00.

Institutional Trading of Xometry

Several institutional investors have recently made changes to their positions in the stock. Kemnay Advisory Services Inc. bought a new position in shares of Xometry during the 4th quarter valued at $28,000. Quantbot Technologies LP acquired a new position in Xometry in the third quarter worth about $30,000. Westend Capital Management LLC bought a new position in shares of Xometry during the third quarter valued at $41,000. GAMMA Investing LLC grew its position in Xometry by 26.5% during the 4th quarter. GAMMA Investing LLC now owns 773 shares of the company’s stock worth $46,000 after acquiring an additional 162 shares during the last quarter. Finally, Global Retirement Partners LLC acquired a new stake in Xometry in the 3rd quarter valued at about $47,000. 97.31% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting Xometry

Here are the key news stories impacting Xometry this week:

• Positive Sentiment: Citi and Wedbush remain constructive on Xometry despite trimming targets — Citi keeps a “buy” rating (target cut to $65) and Wedbush keeps an “outperform” rating (target cut to $60); these sustained bullish ratings temper the negative headlines and signal some analysts still see upside. Xometry (NASDAQ:XMTR) Price Target Cut to $65.00 by Analysts at Citigroup
• Positive Sentiment: Valuation story after strong 2025 results: a recent Yahoo piece assesses Xometry’s valuation in light of solid 2025 revenue growth and an upcoming CEO transition — this frames the company as still fundamentally improving even amid near-term noise. Assessing Xometry (XMTR) Valuation After Strong 2025 Results And Upcoming CEO Transition
• Neutral Sentiment: UBS nudged its target to $55 with a “neutral” rating — a modest change that neither strongly supports nor condemns near-term price action. Xometry (NASDAQ:XMTR) Given New $55.00 Price Target at UBS Group
• Neutral Sentiment: Royal Bank of Canada cut its target to $55 and now lists Xometry as “sector perform” — another mixed signal that reduces consensus upside but isn’t a full-scale downgrade. Xometry (NASDAQ:XMTR) Price Target Cut to $55.00 by Analysts at Royal Bank Of Canada
• Negative Sentiment: Market reaction / analyst downgrade headline — outlets reported Xometry trading down after analyst downgrades/target cuts, contributing to today’s weakness in the stock. Xometry (NASDAQ:XMTR) Trading Down 7.3% After Analyst Downgrade
• Negative Sentiment: Large insider sales by multiple senior executives (CEO, CFO, President, CTO and others) were disclosed on Feb. 26 — sizable, contemporaneous insider selling typically raises investor concern about insider sentiment and adds pressure to the share price. SEC filing (CEO sale) linked for reference. SEC filing – CEO sale
• Negative Sentiment: Reported Q4/2025 earnings call transcript excerpts were circulated saying Xometry missed EPS expectations — if investors treat those reports as accurate, they amplify downside pressure despite other outlets reporting a beat; the earnings narrative remains a source of confusion and volatility. Xometry, Inc. (NASDAQ:XMTR) Q4 2025 Earnings Call Transcript

Xometry Company Profile

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.